JAGX
Income statement / Annual
Last year (2023), Jaguar Health, Inc.'s total revenue was $9.76 M,
a decrease of 18.36% from the previous year.
In 2023, Jaguar Health, Inc.'s net income was -$41.30 M.
See Jaguar Health, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$9.76 M
|
$11.96 M
|
$4.34 M
|
$9.39 M
|
$5.78 M
|
$4.42 M
|
$4.36 M
|
$141,523.00
|
$258,381.00
|
$0.00
|
| Cost of Revenue |
$4.43 M |
$2.02 M |
$2.33 M |
$3.28 M |
$3.82 M |
$2.77 M |
$880,405.00 |
$51,966.00 |
$123,457.00 |
$0.00 |
| Gross Profit |
$5.34 M |
$9.94 M |
$2.00 M |
$6.11 M |
$1.96 M |
$1.65 M |
$3.48 M |
$89,557.00 |
$134,924.00 |
$0.00 |
| Gross Profit Ratio |
0.55 |
0.83 |
0.46 |
0.65 |
0.34 |
0.37 |
0.8 |
0.63 |
0.52 |
0 |
| Research and Development
Expenses |
$18.60 M
|
$17.65 M
|
$15.08 M
|
$6.41 M
|
$5.82 M
|
$5.15 M
|
$4.27 M
|
$7.21 M
|
$6.48 M
|
$4.22 M
|
| General & Administrative
Expenses |
$15.71 M
|
$17.87 M
|
$17.10 M
|
$14.39 M
|
$13.50 M
|
$12.28 M
|
$11.25 M
|
$5.98 M
|
$5.34 M
|
$0.00
|
| Selling & Marketing
Expenses |
$6.46 M
|
$8.84 M
|
$8.89 M
|
$6.61 M
|
$6.94 M
|
$9.83 M
|
$3.08 M
|
$485,440.00
|
$765,091.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$20.66 M
|
$26.71 M
|
$26.00 M
|
$21.00 M
|
$20.44 M
|
$22.11 M
|
$14.33 M
|
$6.47 M
|
$6.10 M
|
$4.10 M
|
| Other Expenses |
$371,000.00 |
$950,000.00 |
-$765,000.00 |
$190,000.00 |
$648,800.00 |
$315,691.00 |
$88,549.00 |
-$11,046.00 |
-$27,277.00 |
$0.00 |
| Operating Expenses |
$39.26 M |
$44.35 M |
$41.08 M |
$27.41 M |
$26.91 M |
$27.26 M |
$18.60 M |
$13.68 M |
$12.58 M |
$8.32 M |
| Cost And Expenses |
$43.68 M |
$46.37 M |
$43.41 M |
$30.69 M |
$30.72 M |
$30.03 M |
$19.48 M |
$13.73 M |
$12.70 M |
$8.32 M |
| Interest Income |
$0.00 |
$12.72 M |
$8.42 M |
$2.79 M |
$5.73 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
-$6.38 M |
$12.72 M |
$8.42 M |
$2.79 M |
$5.73 M |
$2.63 M |
$1.21 M |
$985,549.00 |
$3.32 M |
$0.00 |
| Depreciation &
Amortization |
$2.39 M
|
$2.29 M
|
$1.83 M
|
$2.28 M
|
$1.93 M
|
$1.75 M
|
$584,339.00
|
$47,494.00
|
$5,155.00
|
-$51,423.00
|
| EBITDA |
-$31.53 M
|
-$31.17 M
|
-$39.66 M
|
-$24.18 M
|
-$22.94 M
|
-$20.07 M
|
$4.37 M
|
-$13.39 M
|
-$11.94 M
|
-$8.37 M
|
| EBITDA Ratio |
-3.23 |
-2.61 |
-9.15 |
-2.58 |
-3.97 |
-4.55 |
1 |
-94.59 |
-46.21 |
0 |
| Operating Income Ratio
|
-3.48
|
-2.88
|
-9.01
|
-2.27
|
-4.32
|
-6.98
|
-7.85
|
-96
|
-48.17
|
0
|
| Total Other
Income/Expenses Net |
-$7.98 M
|
-$13.98 M
|
-$13.53 M
|
-$12.51 M
|
-$13.58 M
|
-$3.90 M
|
-$18.82 M
|
-$162,246.00
|
-$528,894.00
|
$51,423.00
|
| Income Before Tax |
-$41.90 M |
-$48.40 M |
-$52.60 M |
-$33.81 M |
-$38.53 M |
-$32.15 M |
-$35.15 M |
-$14.73 M |
-$16.29 M |
-$8.61 M |
| Income Before Tax Ratio
|
-4.29
|
-4.05
|
-12.13
|
-3.6
|
-6.67
|
-7.28
|
-8.06
|
-104.11
|
-63.05
|
0
|
| Income Tax Expense |
-$601,000.00 |
-$941,000.00 |
$7.65 M |
$2.98 M |
$10,000.00 |
-$1.28 M |
-$13.18 M |
$1.14 M |
$3.82 M |
$345,336.00 |
| Net Income |
-$41.30 M |
-$47.45 M |
-$60.25 M |
-$36.79 M |
-$38.54 M |
-$32.15 M |
-$21.97 M |
-$14.73 M |
-$16.29 M |
-$8.61 M |
| Net Income Ratio |
-4.23 |
-3.97 |
-13.9 |
-3.92 |
-6.67 |
-7.28 |
-5.04 |
-104.11 |
-63.05 |
0 |
| EPS |
-107.42 |
-36.18 |
-101.07 |
-214.22 |
-1746.39 |
-15507.02 |
-27256.34 |
-249725.08 |
-479163.24 |
-204989.88 |
| EPS Diluted |
-107.42 |
-36.18 |
-101.07 |
-214.22 |
-1746.39 |
-15507.02 |
-27256.34 |
-249725.08 |
-479163.24 |
-204989.88 |
| Weighted Average Shares
Out |
$384,474.00
|
$1.31 M
|
$596,154.00
|
$171,745.00
|
$22,068.00
|
$2,073.00
|
$806.00
|
$59.00
|
$34.00
|
$42.00
|
| Weighted Average Shares
Out Diluted |
$384,474.00
|
$1.31 M
|
$596,154.00
|
$171,745.00
|
$22,068.00
|
$2,073.00
|
$806.00
|
$59.00
|
$34.00
|
$42.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
